From the Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, TN.
Department of Plastic Surgery, Cleveland Clinic Florida, Weston, FL.
Ann Plast Surg. 2023 May 1;90(5):506-515. doi: 10.1097/SAP.0000000000003524. Epub 2023 Mar 8.
There are mixed results in surgical complications regarding the usage of prepectoral versus subpectoral implant placement in direct-to-implant breast reconstruction. This study aimed to provide a comprehensive synthesis of surgical complications between the subpectoral and prepectoral reconstructive method.
PubMed, Embase, and Cochrane were searched for literature published up until December 2022. Studies that compared subpectoral and prepectoral breast reconstruction and reported at least one postoperative complication were included. The following 8 major outcomes were included: revision and reoperation, capsular contracture, explantation, seroma, hematoma, infection, skin necrosis, and animation deformity. Systematic review and meta-analysis were performed to compare outcomes of the 2 techniques. Subgroup analysis was performed to compare whether practice differences in different countries may have an impact on outcomes.
A total of 18 studies were identified in our literature search. Two thousand three hundred sixty patients were included, representing a total of 3135 breasts. Our analysis demonstrated that prepectoral reconstruction had significantly lower odds of developing postoperative hematoma [odds ratio (OR), 0.62; P = 0.05], seroma (OR, 0.67; P = 0.01), infection (OR, 0.64; P = 0.03), revision and reoperation (OR, 0.44; P < 0.00001), and animation deformity (OR, 0.01; P < 0.00001), compared with the subpectoral method. Subgroup analysis showed that differences between 3 countries (United States, Korea, Italy) are low (all subgroup heterogeneity test P > 0.1).
While both subpectoral and prepectoral are safe methods for breast reconstruction, the prepectoral technique may lead to lower odds of developing multiple major postoperative complications.
在直接乳房植入物重建中,胸肌下和胸肌前植入物的使用在手术并发症方面存在结果不一的情况。本研究旨在综合比较胸肌下和胸肌前重建方法的手术并发症。
检索了 PubMed、Embase 和 Cochrane 中截至 2022 年 12 月发表的文献。纳入了比较胸肌下和胸肌前乳房重建并报告至少一种术后并发症的研究。纳入了以下 8 种主要结局:翻修和再次手术、包膜挛缩、假体取出、血清肿、血肿、感染、皮肤坏死和活动畸形。对这两种技术的结果进行了系统评价和荟萃分析。进行了亚组分析,以比较不同国家的实践差异是否会对结果产生影响。
在文献检索中,共确定了 18 项研究。共纳入 2360 例患者,共计 3135 例乳房。我们的分析表明,与胸肌下重建相比,胸肌前重建发生术后血肿的几率显著降低[比值比(OR),0.62;P = 0.05]、血清肿(OR,0.67;P = 0.01)、感染(OR,0.64;P = 0.03)、翻修和再次手术(OR,0.44;P < 0.00001)和活动畸形(OR,0.01;P < 0.00001)的几率较低。亚组分析表明,美国、韩国和意大利这 3 个国家之间的差异较小(所有亚组异质性检验 P > 0.1)。
虽然胸肌下和胸肌前都是乳房重建的安全方法,但胸肌前技术可能会降低多种主要术后并发症的发生几率。